Skip to main content

Table 6 Comparison of "degree of severity" of the MRS and its domains. Prevalence in percent (%) and 95% confidence interval (in parenthesis) in the population sample studied in the respective regions (see methods)

From: The Menopause Rating Scale (MRS) scale: A methodological review

 

Europe

North America

Latin America

Asia

Total score

    

No, little (0–4)

28.8 (+/-1.3)

28.0 (+/-2.3)

31.0 (+/-1.7)

40.2 (+/-3.0)

Mild (5–8)

21.9 (+/- 1.2)

23.9 (+/-2.2)

20.2 (+/-1.4)

27.5 (+/-2.8)

Moderate (9–16)

25.1 (+/-1.2)

25.7 (+/-2.2)

26.2 (+/-1.6)

22.8 (+/-2.6)

Severe (17+)

24.3 (+/- 1.2)

22.5 (+/-2.1)

22.7 (+/-1.5)

9.5 (+/-1.8)

Psychological domain

    

No, little (0–1)

35.4 (+/-1.4)

36.8 (+/-2.4)

36.8 (+/-1.6)

41.3 (+/-3.1)

Mild (2–3)

21.8 (+/-1.2)

21.9 (+/-2.1)

21.9 (+/-1.4)

25.4 (+/-2.7)

Moderate (4–6)

19.5 (+/-1.1)

18.7 (+/-2.0)

18.7 (+/-1.4)

21.3 (+/-2.6)

Severe (7+)

23.4 (+/-1.2)

22.5 (+/-2.1)

22.5 (+/-1.7)

12.0 (+/-2.0)

Somato-vegetative domain

    

No, little (0–2)

39.5 (+/-1.4)

37.9 (+/-2.4)

42.1 (+/-1.8)

46.8 (+/-3.1)

Mild (3–4)

22.6 (+/-1.2)

25.6 (+/-2.2)

19.4 (+/-1.4)

27.0 (+/-2.8)

Moderate (5–8)

24.2 (+/-1.2)

24.3 (+/-2.2)

25.6 (+/-1.6)

20.8 (+/-2.5)

Severe (9+)

13.7 (+/-1.0)

12.1 (+/-1.7)

12.9 (+/-1.2)

5.4 (+/-1.4)

Urogenital domain

    

No, little (0)

34.3 (+/-1.3)

33.4 (+/-2.4)

28.2 (+/-1.8)

55.6 (+/-3.1)

Mild (1)

17.2 (+/-1.1)

17.0 (+/-2.0)

18.6 (+/-1.1)

18.6 (+/-2.4)

Moderate (2–3)

23.0 (+/- 1.2)

24.2 (+/-2.2)

21.8 (+/-1.3)

17.0 (+/-2.3)

Severe (4+)

25.6 (+/-1.2)

25.4 (+/-2.2)

31.4 (+/-1.3)

8.8 (+/-1.8)